Strides Arcolab shines on reporting net profit of Rs 31.57 crore in Q1

25 Apr 2013 Evaluate

Strides Arcolab is currently trading at Rs. 824.50, up by 3.20 points or 0.39 % from its previous closing of Rs. 821.30 on the BSE.

The scrip opened at Rs. 822.05 and has touched a high and low of Rs. 837.25 and Rs. 813.00 respectively. So far 114832 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 630.00 on 26-Apr-2012.

Last one week high and low of the scrip stood at Rs. 844.90 and Rs. 813.30 respectively. The current market cap of the company is Rs. 4859.97 crore.

The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 55.84% and 16.77% respectively.

Strides Arcolab has reported results for first quarter ended March 31, 2013.

The company has reported a net profit of Rs 31.57 crore for the quarter ended March 31, 2013 as compared to a net loss of Rs 28.16 crore for the same quarter in the previous year. Total income from operation of the company has increased by 33.49% at Rs 195.05 crore for quarter under review as compared to Rs 146.12 crore for the quarter ended March 31, 2012.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

887.10 -3.30 (-0.37%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×